Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2009
11/19/2009US20090286873 AI-2 compounds and analogs based on Salmonella typhimurium LsrB structure
11/19/2009US20090286865 Potentiator of antitumoral agents in the treatment of cancer
11/19/2009US20090286858 Assays for modulators of asparaginyl hydroxylase
11/19/2009US20090286855 Interleukin-18 mutants, their production and use
11/19/2009US20090286849 Modulation of insulin like growth factor i receptor expression
11/19/2009US20090286843 Macrocyclic compounds as inhibitors of viral replication
11/19/2009US20090286753 Novel oligonucleotide compositions and probe sequences useful for detection and analysis of micrornas and their target mrnas
11/19/2009US20090286748 using polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence; comprising a NEMO binding domain (NBD)
11/19/2009US20090286747 Mntf peptide compositions and methods of use
11/19/2009US20090286746 Small Survival-Promoting/Immunomodulatory Peptide for Treatment of Brain Damage, Neurodegenerative Disorders, and Inflammatory Disorders
11/19/2009US20090286745 Inhibition of alpha-synuclein aggregation
11/19/2009US20090286744 Treatment of asthma
11/19/2009US20090286743 Methods and Compositions for Treating Conditions of the Eye
11/19/2009US20090286742 polypeptides comprising amino acid sequences corresponding to, similar to or homologous to part of the amino acid sequence of neural thread proteins, used for treating unwanted cellular proliferations such as benign prostatatic hyperplasia, cancer, unwanted facial hair, warts and fatty tissues
11/19/2009US20090286741 Methods for improving the structure and function of arterioles
11/19/2009US20090286740 Peptides and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
11/19/2009US20090286739 Peptides, peptidomimetics and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
11/19/2009US20090286738 Gene Regulation
11/19/2009US20090286737 Erbb interface peptidomimetics and methods of use thereof
11/19/2009US20090286736 using polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence; comprising a NEMO binding domain (NBD)
11/19/2009US20090286735 Method for administering glp-1 molecules
11/19/2009US20090286734 Pharmaceutical Use of Alpha Antigen or Alpha Antigen Gene
11/19/2009US20090286733 Long-acting veterinary polypeptides and methods of producing and administering same
11/19/2009US20090286732 Compounds for delivery of therapeutic and imaging moieties to nerve cells
11/19/2009US20090286731 Methods and compositions for the treatment of xerostomia
11/19/2009US20090286730 Remedies for ischemia
11/19/2009US20090286729 Epidermal Growth Factor Receptor Antagonists and Methods of Use
11/19/2009US20090286728 Tooth root formation promoting factors and method for promotion of tooth root formation
11/19/2009US20090286727 DP-78-Like Nanobodies
11/19/2009US20090286726 Use of the long pentraxin ptx3 for the prevention or treatment of viral diseases
11/19/2009US20090286725 Peptides and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
11/19/2009US20090286724 Aggregable glp-1 analogue and sustained-release pharmaceutical composition
11/19/2009US20090286723 Hybrid Polypeptides with Selectable Properties
11/19/2009US20090286722 Analogs of Gastric Inhibitory Polypeptide as a Treatment for Age Related Decreased Pancreatic Beta Cell Function
11/19/2009US20090286721 Targeted plasminogen activator fusion proteins as thromobolytic agents
11/19/2009US20090286720 Pharmaceutical composition for the diagnosis, prevention or treatment of a tumoral pathology comprising an agent modulating the polymerization state of actin
11/19/2009US20090286719 Modification of cupredoxin derived peptides and methods of use thereof
11/19/2009US20090286718 Stable Aqueous Cyclosporin Compositions
11/19/2009US20090286717 Glycopeptide Antibiotic Derivative
11/19/2009US20090286716 Soluble Pharmaceutical Compositions for Parenteral Administration Comprising a GLP-1 Peptide and an Insulin Peptide of Short Time Action for Treatment of Diabetes and Bulimia
11/19/2009US20090286715 Pharmaceutical Composition
11/19/2009US20090286714 Novel molecules of the card-related protein family and uses thereof
11/19/2009US20090286713 Collagen Receptor I-Domain Binding Modulators
11/19/2009US20090286316 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer
11/19/2009US20090286273 Use of neuregulin-beta as an indicator and/or target
11/19/2009US20090286270 Method for treating pervasive development disorders
11/19/2009US20090285908 Method of treating endothelial injury
11/19/2009US20090285895 Pharmaceutical Formulation for Regulating the Timed Release of Biologically Active Compounds Based on a Polymer Matrix
11/19/2009US20090285890 Antimicrobial peroxidase compositions
11/19/2009US20090285880 Dried reconstituted vesicle formation for pharmaceutical application
11/19/2009US20090285874 Implantable Devices For Accelerated Healing
11/19/2009US20090285863 Coating Composition Comprising Starch
11/19/2009US20090285859 Allergenic proteins of natural rubber latex, their production and use in assays
11/19/2009US20090285846 Mutants of cholesterol-dependent cytolysins and uses thereof
11/19/2009US20090285843 Epitope sequences
11/19/2009US20090285839 Antigen uptake receptor for candida albicans on dendritic cells
11/19/2009US20090285838 Use of soluble cd164 in inflammation and autoimmune disorders
11/19/2009US20090285833 Clostridium botulinum c3 exotransferase compositions and methods for treating tumour spreading
11/19/2009US20090285826 Combination drugs comprising vegf inhibitor and serine proteases/thrombolytic compounds for treating neovascular disorders
11/19/2009US20090285825 Novel snake toxin
11/19/2009US20090285823 Glycopeptides derived from pancreatic structures, antibodies and applications thereof in diagnostics and therapeutics
11/19/2009US20090285822 Prevention and treatment of amyloidogenic disease
11/19/2009US20090285817 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene
11/19/2009US20090285816 Albumin Fusion Proteins
11/19/2009US20090285815 Immunoconjugates comprising cd4 and immunoglobin molecules for the treatment of hiv infection
11/19/2009US20090285814 CD 40 Binding Molecules and CTL Pepetides for Treating Tumors
11/19/2009US20090285809 Prevention and treatment of amyloidogenic diseases
11/19/2009US20090285804 Anti-ADDLs antibodies and uses thereof
11/19/2009US20090285801 Calcium-Sensing Receptor 2 (CaR2) and Methods for Using
11/19/2009US20090285800 Aberrant expression of CKS1 and CKS2 and uses thereof
11/19/2009US20090285798 Cd4 mimic peptides and their uses
11/19/2009US20090285793 Thrombinase having a molecular weight of 31,000 to 32,000; used for dissolving blood clots; culturing a filtrate of Bacillus sphaericus sero type H5a 5b; filtration, salting out the retentate, decolourizing, purifying and dialyzing.
11/19/2009US20090285792 Compositions and methods for treatment of neovascular diseases
11/19/2009US20090285791 Regenerating and enhancing development of muscle tissue
11/19/2009US20090285790 Methods of treating and diagnosing parkinsons disease and related dysautonomic disorders
11/19/2009US20090285786 Method to modulate hematopoietic stem cell growth
11/19/2009US20090285785 External Agent for Treatment of Skin Ulcer
11/19/2009US20090285782 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
11/19/2009US20090285781 Medicament and a method of treating a pathological syndrome
11/19/2009US20090285780 Peg linker compounds and biologically active conjugates thereof
11/19/2009US20090285779 Induction of apoptosis in toll-like receptor expressing tumor cells
11/19/2009US20090285778 Use of interleukin-19 to treat cervical cancer
11/19/2009US20090285777 Uses of Mammalian Cytokine; Related Reagents
11/19/2009US20090285776 Irreversibly-inactivated pepsinogen fragments for modulating immune function
11/19/2009US20090285775 Treatment of wounds using il-17b
11/19/2009US20090285774 Hepatitis C Virus Inhibitors
11/19/2009US20090285773 Hepatitis C Virus Inhibitors
11/19/2009US20090285772 Quinoline derivatives for modulating dna methylation
11/19/2009US20090285771 Methods and compositions for needleless delivery of macromolecules
11/19/2009US20090285770 Topical Compositions for Promoting Homeostasis of the Skin
11/19/2009US20090285762 Imaging methods and compositions comprising fluorescent dyes associated with viral components for nerve imaging
11/19/2009US20090285754 Peptides for targeting apoptotic cells and uses thereof
11/19/2009US20090285753 Novel haptotactic peptides
11/19/2009US20090285752 Immunotherapy of b cell malignancies and autoimmune diseases using unconjugated antibodies and conjugated antibodies and antibody combinations and fusion proteins
11/19/2009US20090285750 Agent, composition and method
11/19/2009DE102008016275A1 Composition, useful e.g. transfection comprises a non-viral gene delivery system containing e.g. cationic lipid, and an agent for partial suppression and/or activation of innate intracellular and/or intercellular immune defense
11/19/2009CA2760041A1 Methods and compositions for the treatment of cancer
11/19/2009CA2727803A1 Metal abstraction peptide (map) tag and associated methods
11/19/2009CA2724630A1 Targeted coagulation factors and method of using the same
11/19/2009CA2724542A1 Method of preventing premature delivery
1 ... 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 ... 3163